Mind map
Exam 2: Meglitinides
Map content
Exam 2: Meglitinides
Pharmacokinetics
- Rapid absorption & elimination
- Metabolized in the liver
- Biliary excretion
Pharmacological action
- Increase pancreatic insulin production during and after meals
Adverse effects
- Hypoglycemia
Contraindications
- Renal Impairment
- Hepatic impairment
Drug Interactions
- Gemfibrozil (Lopid) inhibits metabolism, causing hypoglycemia
Nursing Interventions
- LFTs/Cr at baseline
- 2-hr post-prandial glucose
Extra information
- No more than 4 doses per day
- Repaglinide
- Take no more than 30 min before a meal.
- Skipping a dose = Skipping a meal Add a dose if adding a meal
Information
- Description
- User has deleted their subject information Mind Map on Exam 2: Meglitinides, created by Deleted user on 14/07/2022.
- Created by
- Deleted user · Jul 2022
- Updated
- Jul 14, 2022
- Views
- 6
- History
-
- Created by Jasper McClellan · Jul 10, 2022
- Copied by Jasper McClellan · Jul 14, 2022
- Rating